| 000 | 01787 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250512091020.0 | ||
| 264 | 0 | _c19730222 | |
| 008 | 197302s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(73)90463-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBett, J H | |
| 245 | 0 | 0 |
_aAustralian multicentre trial of streptokinase in acute myocardial infarction. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 1973 |
||
| 300 |
_a57-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAustralia |
| 650 | 0 | 4 |
_aBetamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCoronary Care Units |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 |
_aStreptokinase _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aCastaldi, P A | |
| 700 | 1 | _aHale, G S | |
| 700 | 1 | _aIsbister, J P | |
| 700 | 1 | _aMcLean, K H | |
| 700 | 1 | _aO'Sullivan, E F | |
| 700 | 1 | _aBiggs, J C | |
| 700 | 1 | _aChesterman, C N | |
| 700 | 1 | _aHirsh, J | |
| 700 | 1 | _aMcDonald, I G | |
| 700 | 1 | _aMorgan, J J | |
| 700 | 1 | _aRosenbaum, M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 7794 _gp. 57-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(73)90463-7 _zAvailable from publisher's website |
| 999 |
_c4124275 _d4124275 |
||